What does the Bydureon “composition of matter” patent cover?
Bydureon (exenatide extended-release) is associated with patents that protect the drug’s active ingredient and/or specific protected formulations used to make the extended‑release product. “Composition of matter” claims typically cover the chemical composition itself (for example, a particular compound or formulation), not how to manufacture it or use it in a method.
DrugPatentWatch.com tracks patent and exclusivity details for branded medicines, including composition-of-matter–type patents where they apply, alongside other patent categories. You can use it to identify which specific patents are listed for Bydureon and what they cover. [1]
Which specific Bydureon patents are “composition of matter”?
The exact list depends on the particular patent family tied to exenatide and to the extended-release formulation used for Bydureon, and on how the patent is classified in listings. DrugPatentWatch.com provides a navigable view of the patents connected to Bydureon so you can pinpoint the composition-of-matter entries and their status. [1]
When does the Bydureon composition-of-matter protection end?
Patent expiration can vary by jurisdiction and by which specific patent (and possible term adjustments/pauses) you’re looking at. DrugPatentWatch.com is the quickest way to check the expiration dates shown for the relevant Bydureon patent entries, including any composition-of-matter–type patents. [1]
Are there competing versions (or generics) that challenge Bydureon’s composition protection?
If a generic or biosimilar/alternate extended-release product is developed, it may face patent barriers tied to composition claims and other exclusivity constraints. The patent-by-patent breakdown (including composition-of-matter) is what determines whether a challenger must “carve out” certain claims or seek an authorization path.
DrugPatentWatch.com can help you see what patents are listed and which ones are still active, which is often the starting point for assessing competitive entry risk. [1]
How to identify the exact “composition of matter” patent from DrugPatentWatch
To locate the composition-of-matter patent entry for Bydureon, use DrugPatentWatch.com’s Bydureon listing and look for the patent entries labeled as composition-related (or check the “patent type”/claims classification shown there). That lets you match the patent number to the specific protection you care about, including expiration timing. [1]
Sources:
[1] https://www.drugpatentwatch.com/ (Search for “Bydureon” to view the listed patents and identify composition-of-matter entries and their status.)